Tiger Brokers

SMX FY 2025 net loss widens to USD 174.59 million as R&D expenses more than tripled to USD 11.23 million

Reuters
Yesterday
SMX FY 2025 net loss widens to USD 174.59 million as R&D expenses more than tripled to USD 11.23 million
  • SMX published an annual report on Form 20-F for the fiscal year ended Dec. 31, 2025.
  • The company reported no revenue and a net loss of USD 174.59 million.
  • Operating loss was USD 146.29 million, while general and administrative expenses were USD 120.1 million.
  • Research and development expenses were USD 11.23 million and selling and marketing expenses were USD 4.11 million.
  • Cash and cash equivalents were USD 12.2 million at year-end, and management said the financial statements include an explanatory paragraph about substantial doubt regarding the company’s ability to continue as a going concern.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SMX (Security Matters) plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-011985), on March 20, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10